Dr. Prabhakar Salunkhe serves as Head of Research, responsible for all aspects of Amrita Therapeutics Limited's preclinical and clinical research. This includes production of priority target proteins under cGMP condtions, completion of advanced preclinical studies of validated candidates and Phase I through Phase IV human clinical trials, with a focus on multiple disease targeting (MDT) drugs effective against cervical cancer, HIV/AIDs, and other parasites and/or viral infections.
With nearly ten years of research experience in the field of molecular biology and two and half years of operational experience, Prabhakar Salunkhe brings a wealth of relevant knowledge and experience to Amrita Therapeutics Limited. His educational experience includes a M.S. in Biochemistry from North Maharashtra University, Jalgaon, India and Ph. D. awarded in the field of Pseudomonas aeruginosa virulence from Medical Research Institute, Hannover, Germany. Prabhakar also worked on innate immunity and Toll-like Receptor Signaling during his post-doc at the Burnham Institute for Medical Research, San Diego, California, USA. Several papers related to his Ph.D. and post-doctoral studies have been published internationally.
Immediately prior to coming to Amrita Therapeutics Limited, Prabhakar served asTechnology Manager with MWG Biotech Pvt. Ltd. Bangalore, looking after production and quality control of oligonucleotides and DNA sequencing activities. He has also worked as a Senior Research Fellow at the Agharkar Research Institute, Pune, on metal microbe interactions.